Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Publication of NICE guidance makes nilotinib only treatment recommended in first and second-line Ph+ chronic myeloid leukaemia

Publication of NICE guidance makes nilotinib only treatment recommended in first and second-line Ph+ chronic...

Cancer during pregnancy, a challenge that can be overcome

Cancer during pregnancy, a challenge that can be overcome

Study identifies potential treatment for lethal childhood leukaemia

Study identifies potential treatment for lethal childhood leukaemia

Chemotherapy proves life-saving for some leukaemia patients who fail induction therapy

Chemotherapy proves life-saving for some leukaemia patients who fail induction therapy

Lead discovered in origin of chronic lymphatic leukaemia

Lead discovered in origin of chronic lymphatic leukaemia

Novel compound demonstrates anti-leukaemic effect in zebrafish, shows promise for human treatment

Novel compound demonstrates anti-leukaemic effect in zebrafish, shows promise for human treatment

AACR 2012: New biomarker to identify hepatitis B-infected patients at risk for liver cancer

AACR 2012: New biomarker to identify hepatitis B-infected patients at risk for liver cancer

$New fractionated dosing regimen for anticancer drug significantly improves outcomes for leukaemia patients aged 50-70 years$

New fractionated dosing regimen for anticancer drug significantly improves outcomes for leukaemia patients aged 50...

Less intense chemotherapy more effective and less toxic for patients with advanced Hodgkin’s lymphoma

Less intense chemotherapy more effective and less toxic for patients with advanced Hodgkin’s lymphoma

AACR 2012: New, potent epigenetic drug for myelodysplastic syndromes, leukaemia

AACR 2012: New, potent epigenetic drug for myelodysplastic syndromes, leukaemia

More from ecancer